BNP Paribas Aktienanleihe MRK 27..../ DE000PN8DTJ3 /
2024-05-24 9:40:11 PM | Chg.-0.050 | Bid9:52:49 PM | Ask9:52:49 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
100.180EUR | -0.05% | 100.180 Bid Size: 20,000 |
100.280 Ask Size: 20,000 |
MERCK KGAA O.N. | 150.00 EUR | 2024-06-27 | Call |
GlobeNewswire
2:00 PM
CG Oncology to Present Positive Final Results from Phase 2 CORE-001 Study of Cretostimogene Grenaden...
GlobeNewswire
05-23
Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at ...
GlobeNewswire
05-07
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
05-06
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA